IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

A Trautmann, O Boyer, E Hodson, A Bagga… - Pediatric …, 2023 - Springer
Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting
from 1.15 to 16.9 per 100,000 children per year globally. It is characterized by massive …

Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy—short version of the updated German best practice guideline (S2e)—AWMF register …

R Ehren, MR Benz, PT Brinkkötter, J Dötsch… - Pediatric …, 2021 - Springer
Idiopathic nephrotic syndrome is the most frequent glomerular disease in children in most
parts of the world. Children with steroid-sensitive nephrotic syndrome (SSNS) generally …

Levamisole therapy in COVID-19

HM Al-Kuraishy, AI Al-Gareeb, L Alkazmi… - Viral …, 2021 - liebertpub.com
Coronavirus disease 2019 (COVID-19) a global infectious disease caused by severe acute
respiratory coronavirus 2 (SARS-CoV-2) affects various organs, primarily the respiratory …

Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects

AK Mühlig, JY Lee, MJ Kemper, A Kronbichler… - Journal of Clinical …, 2019 - mdpi.com
Steroid sensitive nephrotic syndrome is one of the most common pediatric glomerular
diseases. Unfortunately, it follows a relapsing and remitting course in the majority of cases …

Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options

MJ Kemper, L Valentin, M van Husen - Pediatric nephrology, 2018 - Springer
The idiopathic nephrotic syndrome in childhood can be classified according to the
International Study of Kidney Disease in Children (ISKDC) based on the response to …

Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind …

F Veltkamp, DH Khan, C Reefman, S Veissi… - BMJ open, 2019 - bmjopen.bmj.com
Introduction Idiopathic nephrotic syndrome (INS) is characterised by a high relapse rate up
to 80% after initial response to standard therapy with corticosteroids. Steroid toxicity is …

Adulterants in crack cocaine in Brazil

M Ribeiro, AP Trevizol, R Frajzinger… - Trends in psychiatry …, 2019 - SciELO Brasil
Introduction Brazil is the world's biggest consumer of crack cocaine, and dependence is a
major public health issue. This is the first study to investigate the prevalence of potentially …

Levamisole suppresses activation and proliferation of human T cells by the induction of a p53‐dependent DNA damage response

GH Khan, F Veltkamp, M Scheper… - European journal of …, 2023 - Wiley Online Library
Levamisole (LMS) is a small molecule used in the treatment of idiopathic nephrotic
syndrome (INS). The pathogenesis of INS remains unknown, but evidence points toward an …

Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C

F Veltkamp, A Bökenkamp, J Slaats, H Hamer… - Pediatric …, 2022 - Springer
Background In pediatric patients treated with levamisole to prevent relapses of idiopathic
nephrotic syndrome (INS), a transient and non-progressive rise in creatinine levels has been …

Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysis

GC Bhatt, B Patel, RR Das, S Malik… - Indian Journal of …, 2023 - journals.lww.com
Present evidence regarding the efficacy and safety of levamisole in childhood nephrotic
syndrome (NS), particularly the steroid-sensitive NS (SSNS), is limited. We searched …